Xinxin Pharmaceutical Factory

Zhejiang Xinxin Pharmaceutical is a Chinese pharmaceutical manufacturer specializing in chemical drugs and traditional Chinese medicine (TCM) preparations. The company produces a variety of oral dosage forms, including tablets, capsules, and granules, with a focus on therapeutic areas such as cardiovascular health, gastroenterology, and respiratory medicine. In 2014, it became a subsidiary of Zhejiang Jolly Pharmaceutical, which facilitated the integration of its chemical drug portfolio with Jolly's established TCM market presence. The company's facilities are GMP-certified, supporting both domestic supply and potential international export of generic pharmaceuticals. Key products in its commercial portfolio include Rosuvastatin for cholesterol management and Omeprazole for gastric conditions.